Transfusion Related Complication
23
5
6
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.3%
1 terminated out of 23 trials
88.9%
+2.4% vs benchmark
13%
3 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (23)
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
Transfusion Surveillance in Anaesthesia
Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery
Individualized ANH for Non-cardiac Surgery
Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit
Warmed Blood Transfusion in Premature Infants
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion Requirement
Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation
PRospective Multicenter Observational Study on Transfusion Practice in Vv-ECMO Patients: The PROTECMO Study
Cord Blood Transfusion In Preterm Neonates (CB-TrIP)
Monitoring Noninvasively for Infusion and Transfusion Optimization
Patient Blood Management for Massive Obstetric Hemorrhage
Effects of Therapeutic Plasmaexhange on Viscoelastic Tests in Non-coagulopathic Patients
Effects of Packed Red Blood Cell Storage Duration on Pediatric Living Donor Liver Transplantation
Implementation of a Patient Blood Management Program in Gastric Cancer Surgery
Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.
Transfusion Strategy in Hematological Intensive Care Unit
Proficiency Based Training to Investigate WBIT
Restrictive Versus Liberal Transfusion, Major Surgeries